Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. - Wikidata - wikimedia - TriplyDB

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q39332284

about

Personalized management of cirrhosis by non-invasive tests of liver fibrosis.Molecular prognostic prediction in liver cirrhosis Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Screening for hepatocellular carcinoma: patient selection and perspectives Risk prediction models for hepatocellular carcinoma in different populations.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Liver ultrasound elastography: More than staging the disease.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.Hepatic stellate cells: central modulators of hepatic carcinogenesis.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Virus and Host Testing to Manage Chronic Hepatitis B.Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine.Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease.Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.Contemporary use of elastography in liver fibrosis and portal hypertension.The prognosis and management of inactive HBV carriers.Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.Liver biopsy: past, present and future.Critical comparison of elastography methods to assess chronic liver disease.Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Surveillance of the Patients with High Risk of Hepatocellular Cancer.Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial.HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus.Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers.The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet.Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects.Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.

P2860

Q26777483-E5D1E238-D3E7-4224-A341-E0B0902C7641 Q26784251-DB4A7F10-8A78-418E-BADF-F02D628CF622 Q28066959-83CF77E0-FFDF-45A4-812E-F93426E2A983 Q30244651-34727C0B-9D84-4662-AE9A-A53ABB3ECD71 Q30355713-5319035C-3DFA-4CC9-8C63-80ADE86125F3 Q30383460-A3389573-BED7-42FC-96E4-E4A7D6CA6C73 Q30391932-FC7F7F7A-171F-400F-B58D-6FCDE296168B Q30407629-60F1F1C7-65F7-4348-A595-FC275FA75A63 Q30430774-BAF121F2-E620-40DA-8101-01583870F3F6 Q33872964-DAFBDB1F-B742-43D5-A53A-35DAC9825FAF Q35642468-C49C2770-ACBD-4AFE-A72A-7F56577C426B Q35881575-13A0AFEF-D539-4F9E-8B05-926F323EB083 Q36958940-29BA17D1-8124-47B0-A04A-0A1F13BA3DCC Q36993037-FBE60184-21C4-4FFC-A8C0-02FEF55398FD Q37207070-DDE5B927-7151-48D7-9558-ECA13244AEA5 Q37497024-FA502571-51AD-4ED1-9A43-C62ACB679E11 Q37702167-C816D3AE-B1F6-4DA7-98FF-EBB7614377D8 Q38212222-05EBC50F-0B88-4CD1-8A4E-D6BC5FDA4854 Q38224416-F4B3FF91-33A7-4B37-BE5D-D767DFDD6E50 Q38605327-E44287A9-69EE-453A-880D-7B97181CF70E Q38685595-BE226772-97CA-4E10-BE47-3CF0C9F00B91 Q38708562-99B867A9-429E-4F17-9CBE-6BA3C80F660C Q38732936-1F59C663-912D-4C9D-946C-A7BC4C093F7F Q38858344-5D1121AD-2F04-46D9-A152-36124D6F1C11 Q38948862-4CF23AB5-88EF-4E17-8AF5-697D98A9225B Q39197775-25A0B5BE-2FC0-4D79-A3FF-2724C240A6D8 Q39387245-D4E2604F-3770-4CA3-A403-EB8B357A65CC Q40065167-A7EFCC19-7977-4A5D-B593-8454494A72D7 Q40065385-A5712920-B879-4D04-9D2E-D586F378E765 Q40347780-066B91F4-5DBF-448A-8F1A-F81391A33B69 Q40528074-E6F01E2F-CAD2-42F9-A3D3-E03B72A8E1C1 Q40537499-682DCB23-AC92-475B-8B14-41359F2FE40D Q40985515-1209C339-3B0D-47B7-9CED-79BE68DC9E4A Q41021645-D7D714FC-03DB-4C52-96A7-75CD5F64D557 Q41065754-E3B30B8D-40C8-4EB8-AB76-3D24454E122D Q41921861-81A7CED9-B108-44B9-860E-2B0725274747 Q42173015-C38F4526-36A5-42CA-B7FA-82BDFEF0C300 Q42175529-A2FBD4B6-7F6B-4825-92DC-D0E1C147ED4B Q42386335-A54DCC6D-C5B8-4B99-ACE3-D67187CD9E53 Q45326295-9D852F12-7B19-490F-AED0-AA65F20EAA64

P2860

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

http://www.wikidata.org/entity/Q39332284

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@en

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@nl

type

label

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@en

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@nl

prefLabel

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@en

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@nl

P1433

Q39332284-FC27A825-AC7A-4F7A-92CB-E6B83DAD774A

P1476

Q39332284-F44C9F62-5E29-4796-BCFA-7FA2B85D8D1E

P2093

Q39332284-0D061F35-B02E-4696-A753-AA327C687044

Q39332284-162ABF53-760D-4C2E-9649-32FB322A31D0

Q39332284-3328CF11-AE7E-4D00-B2B8-55368D163E1C

Q39332284-34AE40A8-20E1-4987-AE52-5E321030D9C0

Q39332284-3CE79DAA-3BFE-43E7-A15E-F93EB229AD34

Q39332284-526558A2-FDBC-4828-98C6-C4226861E0ED

Q39332284-9770F0A2-AE2B-4744-810E-1457BCB20005

Q39332284-CEAF654C-6610-48E2-8455-3352CA745A38

Q39332284-D9C03BB9-6131-4171-8450-F337E14BA412

Q39332284-DA67F6D7-11E3-46F5-A8C1-21979BABB3CD

P304

Q39332284-4E14505D-7B57-4122-94C1-7C2BE5BC60E5

P31

Q39332284-3BFE6A9E-E64D-4439-AA7D-9BDA8A0BE3E2

P356

Q39332284-B39ED40C-816E-4917-9F5B-B0242940AC66

P433

Q39332284-2C822432-6B91-4AA7-AFB7-284ECAE9B36D

P478

Q39332284-6DDE5A18-38AD-484A-B13E-19057F5F5B95

P577

Q39332284-3D50E079-021D-4FE0-A2FD-10146D7DC828

P698

Q39332284-4AD5D4E1-33A2-4876-88CF-A25E17691CF9

P921

Q39332284-1B3FB1B9-FAB4-4F83-85C4-BDF793EE4FB3

P356

J.JHEP.2013.09.029

P1433

Journal of Hepatology

P1476

Liver stiffness-based optimiza ...... ents with chronic hepatitis B.

@en

P2093

Angel Mei-Ling Chim

http://www.w3.org/2001/XMLSchema#string

Calvin Leung

http://www.w3.org/2001/XMLSchema#string

Candace Yim Chan

http://www.w3.org/2001/XMLSchema#string

Catherine Ka-Yan Wong

http://www.w3.org/2001/XMLSchema#string

Grace Lai-Hung Wong

http://www.w3.org/2001/XMLSchema#string

Henry Lik-Yuen Chan

http://www.w3.org/2001/XMLSchema#string

Patricia Po-Lai Ho

http://www.w3.org/2001/XMLSchema#string

Tina Kit-Ting Lau

http://www.w3.org/2001/XMLSchema#string

Vincent Wai-Sun Wong

http://www.w3.org/2001/XMLSchema#string

Vivian Chi-Yee Chung

http://www.w3.org/2001/XMLSchema#string

P304

339-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2013.09.029

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24128413

http://www.w3.org/2001/XMLSchema#string

P921